Bioinvent
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates.
Basic Information
- Category: public company
- Founded: 1988
- Website: http://www.bioinvent.com/
Evidence and Sources
- Bioinvent — Official Site (official)
- Bioinvent on linkedin (social)
- Bioinvent — Wikipedia (reference)
Citation Guidance
Explore public company profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Bioinvent.
- Canonical profile: https://brandsource.ai/brands/bioinvent
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/bioinvent/json-ld
- Citation profile API: https://brandsource.ai/api/brands/bioinvent/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.